This Article Full Text (PDF) All Versions of this Article: 0269881108089600v1 23/4/460    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Maron, E Articles by Zharkovsky, A Search for Related Content PubMed PubMed Citation Articles by Maron, E Articles by Zharkovsky, A Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Anxiety Social Bookmarking                         What's this?

CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects

Department of Psychiatry, University of Tartu, Tartu, Estonia; Head of Research Department of Mental Health, The North Estonian Regional Hospital, Psychiatry Clinic, Tallinn, Estonia

I Tõru

Department of Psychiatry, University of Tartu, Tartu, Estonia

K Mäemets

Department of Pharmacology, University of Tartu, Tartu, Estonia

S Sepp

Department of Pharmacology, University of Tartu, Tartu, Estonia

V Vasar

Department of Psychiatry, University of Tartu, Tartu, Estonia

J Shlik

Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada

A Zharkovsky

Department of Pharmacology, University of Tartu, Tartu, Estonia

Abstract

Recent animal studies consistently confirm the involvement of brain-derived neurotrophic factor (BDNF) in the regulation of anxiety-related behaviours. The role of BDNF in human anxiety has been less investigated. The aim of our study was to examine the association between serum BDNF levels and panic/anxiety responses to cholecystokinin-tetrapeptide (CCK-4) challenge in healthy subjects. BDNF concentrations were detected in serum samples of 37 male and female volunteers before and 120 min after CCK-4 injection. The baseline levels of serum BDNF did not predict the occurrence of CCK-4-induced panic attacks or intensity of panic symptoms and did not significantly change 2 h after the challenge. BDNF serum concentrations 120 min after provocation did not differentiate panickers from non-panickers; however, the subjects reporting stronger anxiety response showed higher levels of BDNF than those with mild anxiety. The anxiety net increase on the Visual Analogue Scale, but not severity of panic symptoms, significantly and positively correlated with the change in BDNF concentration from baseline values. This is the first challenge study to demonstrate a possible impact of BDNF on human anxiety. Our findings suggest a general involvement of BDNF in the regulation of anxiety rather than a specific role of BDNF in disposition to panic attacks.

Key Words: anxiety • BDNF • CCK-4 • panic attack • panic challenge

This version was published on June 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 4, 460-464 (2009)
DOI: 10.1177/0269881108089600


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?